People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other, Pharma, Biotechnology, Consumer / Retail, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Atom Tickets, LLC | — | Other | Series C | $58.2M | $998.4M | 2017 |
| Nervgen Pharma Corp. | — | Pharma | Seed | $6.2M | $11.9M | 2019 |
| NRX Pharmaceuticals, Inc. | — | Biotechnology | Seed | $3.5M | $12.3M | 2025 |
| Fitlife Brands, Inc. | — | Consumer / Retail | Seed | $3.0M | $3.8M | 2009 |
| FreeLinc Technologies Inc. | — | Other Technology | Pre-Seed | $896K | $37.9M | 2015 |
| Spartan Bioscience Inc. | — | Biotechnology | Pre-Seed | $260K | $6.1M | 2011 |
Michael Abrams at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Abrams on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Wilson | 1 | 11 |
| Patrick Flynn | 1 | 8 |
| William Adams | 1 | 7 |
| Michael Taylor | 1 | 7 |
| Chaim Hurvitz | 1 | 6 |
| Brian Eric Bayley | 1 | 5 |
| Brian Bayley | 1 | 4 |
| Michael S Abrams | 1 | 3 |
| Ameesh Paleja | 1 | 3 |
| Michael Stork | 1 | 3 |
| Paul Brennan | 1 | 3 |
| Jonathan Javitt | 1 | 3 |
| Richard Propper | 1 | 2 |
| Grant Dawson | 1 | 2 |
| Seth Yakatan | 1 | 2 |
| John S. Wilson | 1 | 2 |
| Krista McKerracher | 1 | 2 |
| Scott Landow | 1 | 2 |
| Ernest Wong | 1 | 2 |
| Harold Punnett | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.